Sweden Views

Pages

KHK files Abstral NDA in Japan

Orexo's partner, Kyowa Hakko Kirin (KHK) has submitted an NDA in Japan for Abstral (fentanyl [KW-2246]) sublingual tablet, developed for the treatment of breakthrough cancer pain. The product has...

Read article ›
Developed States Industry Overview

BMI View: Our outlook for the power sector of developed states is relatively bearish, as we expect economic growth in most of these countries to remain weak, thus weighing on power consumption. The...

Read article ›

Pages